Search
for
Sort by
Research 31–60 of 1000+
- 77200 Infections and Therapy Lapses Predominate as Flare Triggers on Oral JAK Inhibitors for Alopecia Areata: A Retrospective Cohort Study
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Emerging drugs for alopecia areata: JAK inhibitors
- Oral Baricitinib Restores Hair Loss in Alopecia Areata
- Treatment of severe alopecia areata with oral tofacitinib: A case series
- Tratamento adjuvante com minoxidil oral para tratamento de alopecia areata refratária a inibidores de JAK
- Combined Low Dose Oral Minoxidil and Immunomodulator Efficacy and Safety in Alopecia Areata: A Systematic Review
- Jak inhibitors in the treatment of alopecia areata - a literature review
- BH04 Growing interest: a survey of low-dose oral minoxidil prescribing for hair loss
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Effectiveness of oral tofacitinib treatment on patients with moderate‐to‐severe alopecia areata in Iran
- PSS20 MEDIATION MODELING AND MEASUREMENT CHARACTERISTICS OF THE ITCH SEVERITY SCORE FROM A PHASE 2B TRIAL OF ORAL CP-690-550 IN PATIENTS WITH MODERATE TO-SEVERE PLAQUE PSORIASIS
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- Janus kinase inhibitors: An innovative treatment for alopecia areata
- Perceived Efficacy and Risks of Janus Kinase Inhibitors in Pediatric and Young Adult Alopecia Areata: A Cross‐Sectional Survey
- Experience in treating multifocal alopecia areata in a child with Jak kinase inhibitors
- Janus Kinase inhibitors in dermatology: a review
- Ritlecitinib: First Approval
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- An Updated in the Management of Alopecia Areata
- Treatment modalities for lymphocytic and neutrophilic scarring alopecia